Related Experiment Video
Updated: Sep 29, 2025
Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization
Published on: June 7, 2016
Breast Cancer Subtype-Specific miRNAs: Networks, Impacts, and the Potential for Intervention
Raj Pranap Arun1, Hannah F Cahill1, Paola Marcato1,2,3
1Department of Pathology, Dalhousie University, Halifax, NS B3H 4R2, Canada.
Abstract:
The regulatory and functional roles of non-coding RNAs are increasingly demonstrated as critical in cancer. Among non-coding RNAs, microRNAs (miRNAs) are the most well-studied with direct regulation of biological signals through post-transcriptional repression of mRNAs. Like the transcriptome, which varies between tissue type and disease condition, the miRNA landscape is also similarly altered and shows disease-specific changes. The importance of individual tumor-promoting or suppressing miRNAs is well documented in breast cancer; however, the implications of miRNA networks is less defined. Some evidence suggests that breast cancer subtype-specific cellular effects are influenced by distinct miRNAs and a comprehensive network of subtype-specific miRNAs and mRNAs would allow us to better understand breast cancer signaling. In this review, we discuss the altered miRNA landscape in the context of breast cancer and propose that breast cancer subtypes have distinct miRNA dysregulation. Further, given that miRNAs can be used as diagnostic and/or prognostic biomarkers, their impact as novel targets for subtype-specific therapy is also possible and suggest important implications for subtype-specific miRNAs.
Insights
MicroRNAs (miRNAs) play critical roles in cancer, with distinct patterns observed in breast cancer subtypes. Understanding these miRNA networks offers insights into breast cancer signaling and potential therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Non-coding RNAs, particularly microRNAs (miRNAs), are crucial regulators in cancer development.
- miRNA expression profiles are altered in disease states, mirroring transcriptome variability.
- While individual miRNA roles in breast cancer are known, network implications remain less defined.
Purpose of the Study:
- To review the altered miRNA landscape in breast cancer.
- To propose that distinct breast cancer subtypes exhibit specific miRNA dysregulation.
- To highlight the potential of miRNA networks for understanding breast cancer signaling.
Main Methods:
- Review of existing literature on miRNA dysregulation in breast cancer.
- Analysis of miRNA and mRNA network implications across breast cancer subtypes.
- Discussion of miRNA roles as diagnostic/prognostic biomarkers and therapeutic targets.
Main Results:
- Breast cancer subtypes are characterized by distinct miRNA dysregulation patterns.
- miRNA networks significantly influence subtype-specific cellular effects in breast cancer.
- Altered miRNA landscapes are evident across different breast cancer contexts.
Conclusions:
- Breast cancer subtypes display unique miRNA dysregulation, impacting signaling pathways.
- Comprehensive miRNA-mRNA networks are essential for understanding breast cancer heterogeneity.
- Subtype-specific miRNAs hold promise as diagnostic biomarkers and therapeutic targets for personalized breast cancer treatment.
Related Concept Videos
01:22MicroRNAs
02:39lncRNA - Long Non-coding RNAs